Biting the 'Bullet': Amazing new JWST photo shows titanic collision of galaxy clusters
NASA's James Webb Space Telescope (JWST) has produced a new image of the Bullet Cluster, which is a titanic collision between two individual galaxy clusters.
The image, produced in conjunction with NASA's Chandra X-ray Observatory, reveals not only the location and mass of dark matter present, but also points the way toward one day figuring out what dark matter is actually made of.
In the new image, we see the hot gas within the Bullet Cluster in false-color pink, detected by Chandra. The inferred location of dark matter is represented in blue (also false color), as measured by the JWST. Note that the blue and the pink are separate — what has caused the dark matter and the gas to separate, and how were astronomers able to produce this map of the material within the Bullet Cluster?
Located 3.9 billion light-years away, the Bullet Cluster has been an occasionally controversial poster child for dark-matter studies. Back in 2006, the Hubble Space Telescope and the Chandra X-ray Observatory worked together to image the Bullet, showing the presence of its dark matter based on how light from more distant galaxies was being gravitationally lensed by the dark matter's mass.
Collisions between galaxy clusters are the perfect laboratories for testing our ideas about dark matter, because they are nature's way of throwing together huge amounts of the stuff. This gives us a chance to test how dark matter particles interact with each other, if at all, and the degree of any interaction would be a huge clue as to the properties of the mysterious dark matter particle.
Yet despite the dramatic Hubble and Chandra images, the Bullet Cluster — and, indeed, other galaxy cluster collisions — haven't always played ball. For instance, the velocities at which the sub-clusters are colliding seem too high for the standard model of cosmology to explain.
Now the JWST has entered into the fray. A team led by Ph.D. student Sangjun Cha of Yonsei University in Seoul, South Korea, and professor of astronomy James Jee at both Yonsei and the University of California, Davis, have used the most powerful space telescope ever built to get a best-ever look at the Bullet Cluster.
Hubble and Chandra had previously shown that, as the two individual galaxy clusters in the Bullet Cluster collided, the galaxies and their surrounding dark matter haloes had passed right through each other. This makes sense for the galaxies — the distances between them are so great that the chance of a head-on collision between any two is slim. It also suggests that the degree with which dark matter particles interact with each other — what we refer to as their collisional cross section — is small; otherwise, the interaction would have slowed the clouds of dark matter down, and we would detect it closer to where Chandra sees the hot, X-ray emitting intracluster gas. In contrast to the dark matter, these huge gas clouds can't get out of each other's way, so they slam into each other and don't progress any further.
The end result is that the hot gas is found stuck in the middle of the collision, and the galaxies and dark matter belonging to each sub-cluster are found on opposite sides, having glided right through one another.
"Our JWST measurements support this," Jee told Space.com. "The galaxy distribution closely traces the dark matter."
JWST was able to produce a better map of the distribution of matter, both ordinary and dark, in the Bullet Cluster by detecting, for the first time, the combined glow from billions of stars that have been thrown out of their galaxies and are now free-floating in the space between the galaxies in each sub-cluster. Cha and Jee's team were then able to use the light from these "intracluster stars" to trace the presence of dark matter and gain a more accurate map of its distribution in the Bullet Cluster.
However, this has just raised more mysteries. The more refined map of the dark matter shows that, in the larger sub-cluster, on the left, the dark matter is arranged in an elongated, "hammerhead" shape that, according to Jee, "cannot be easily explained by a single head-on collision."
This elongated mass of dark matter is resolved into smaller clumps centered on what we call the brightest cluster galaxies — giant elliptical galaxies that are the brightest galaxies in the sub-cluster located at its gravitational core. In contrast, the dark matter halo around the sub-cluster on the opposite side is smaller and more compact.
Cha and Jee's team suspect that the elongated, clumpy mass of dark matter could only have formed when that particular sub-cluster, which was a galaxy cluster in its own right before the Bullet collision, underwent a similar collision and merger with another galaxy cluster billions of years before the formation of the Bullet.
"Such an event would have stretched and distorted the dark-matter halo over time, resulting in the elongated morphology that we observe," said Jee.
Despite the new discoveries such as this from JWST's more refined observations of the Bullet cluster, it is still not enough to resolve the issue of the collision velocities of the two sub-clusters.
"Even with these updates, the required collision velocity remains high relative to expectations from cosmological simulations," said Jee. "The tension persists and remains an active area of research."
RELATED STORIES
— What is dark matter?
— James Webb Space Telescope (JWST) — A complete guide
— Astonishing 'halo' of high-energy particles around giant galaxy cluster is a glimpse into the early universe
Dark matter makes up over a quarter of all the mass and energy in the universe, and roughly 85% of all matter, so figuring out its secrets, in particular its collisional cross-section and the cause of those high velocities, is going to be essential if we want to better understand this universe in which we live.
Alas, the JWST observations of the Bullet Cluster alone are not enough to confirm what the collisional cross-section of dark matter must be. However, they do tighten the estimate of the upper limit for the value of the cross-section, constraining the list of possibilities.
Astronomers are already in the process of rigorously measuring as many galaxy cluster collisions as possible, seen from all angles and distances, to try and constrain this value further. Gradually, we'll be able to rule out different models for what dark matter could be, until we're left with just a few. Coupled with experimental data from direct dark matter searches from detectors deep underground, such as the LUX-ZEPLIN experiment at the Sanford Underground Research Facility in South Dakota, we could soon be on the cusp of answering one of science's greatest mysteries: what is dark matter?
The JWST observations were reported on June 30 in The Astrophysical Journal Letters.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Associated Press
an hour ago
- Associated Press
CELFULL Unveils Celfavor NADH Microcapsules: A Breakthrough in Stability That Reshapes the Anti-Aging Industry
CORAL SPRINGS, FL / ACCESS Newswire / July 4, 2025 / CELFULL, a biotechnology company with over 25 years of expertise in anti-aging science, has announced a major breakthrough in longevity innovation: the global launch of Celfavor® NADH Microcapsules, a patented delivery system that resolves the century-long challenge of NADH instability. Journal papers related to NADH This revolutionary technology-protected by seven international invention patents across the U.S., China, Japan, Canada, and South Korea-delivers unprecedented improvements in stability, bioavailability, and targeted delivery, marking a new era in anti-aging therapeutics known as the 'Microcapsule Age.' To accelerate research across the globe, CELFULL has also launched its Global Research Sharing Program, offering free access to the Celfavor® NADH raw material to scientific institutions worldwide. Celfavor®NADH The only effective NADH - Celfavor ® NADH 'The discovery of the therapeutic effect of stabilized NADH is more important to humankind than the discovery of antibiotics.' noted Nobel Laureate Sir John Eccles, underscoring the importance of this innovation. NADH stands for 'nicotinamide adenine dinucleotide (NAD) + hydrogen (H), often dubbed the 'King of Anti-Aging Molecules,' plays a central role in mitochondrial energy production, antioxidant defense, and the activation of longevity proteins. However, its inherent instability-sensitive to heat, light, oxygen, and stomach acid-has severely limited its clinical applications. Conventional NADH degrades by over 70% in one month at room temperature and must be stored at -20°C, making practical use difficult. 7 patents have been certified CELFULL's research team, led by its AI-powered Multi-Target Anti-Aging Institute, spent over a decade solving this problem. The result: Celfavor® NADH Microcapsules, a proprietary technology featuring 250-350μm microcapsules that protect NADH with a multi-core soluble shell made from food-grade materials. In stability tests simulating harsh conditions (40°C / 75% RH), traditional NADH retained only 3.5% of its activity after six months. By contrast, Celfavor® NADH maintained 98.3% activity-demonstrating over 6x shelf-life extension, even without refrigeration or light shielding. The stability of Celfavor® NADH microspheres The Celfavor® NADH Microcapsule system delivers innovation across four dimensions: 1. Enhanced Stability: Microcapsules shield NADH from air, moisture, light, and stomach acid, preserving its full potency in gastrointestinal conditions for up to 4 hours. 2. Targeted Release: Using AI-optimized wall material, the system enables 'zero release in the stomach and sustained release in the intestine.' Simulated intestinal studies show 24-hour continuous release, extending absorption time by 5-8x. 3. Superior Bioavailability: In human trials, a daily dose of 40mg led to a 98% increase in blood NAD⁺ levels, a 3.2x improvement over regular NADH. Performance also surpassed other NAD⁺ precursors like NMN and NR. 4. Formulation Flexibility: Unlike unstable NADH, Celfavor® NADH can be safely co-formulated with vitamins, coenzymes, or peptides in single or multi-ingredient capsules. Celfavor ® NADH microsphere advanced technology surpasses others Celfavor® NADH Microcapsules have been granted seven invention patents and passed all 12 safety evaluations, including cytotoxicity and long-term toxicity tests. It is currently the only NADH raw material globally to pass full-spectrum safety certification. The only globally certified raw material for toxicology and safety experiments 'We are not just creating better products-we are building a platform for the future of longevity,' said Dr. Juliane Hitzel, CEO of CELFULL. 'With this microcapsule technology, we're launching new delivery systems for vitamins, peptides, and more. And by sharing our raw materials with global researchers, we're fostering a collaborative ecosystem that accelerates anti-aging science.' From solving the NADH stability problem to advancing intelligent delivery systems, CELFULL's innovation signals a major milestone in human longevity science. As the Celfavor® NADH Microcapsule technology rolls out globally, the anti-aging industry enters a new chapter-one defined by precision, efficiency, and collaboration. For business cooperation or research partnerships, please contact: [email protected] | Email: [email protected] Website: SOURCE: CELFULL press release
Yahoo
3 hours ago
- Yahoo
CELFULL Unveils Celfavor NADH Microcapsules: A Breakthrough in Stability That Reshapes the Anti-Aging Industry
CORAL SPRINGS, FL / / July 4, 2025 / CELFULL, a biotechnology company with over 25 years of expertise in anti-aging science, has announced a major breakthrough in longevity innovation: the global launch of Celfavor® NADH Microcapsules, a patented delivery system that resolves the century-long challenge of NADH instability. Journal papers related to NADH This revolutionary technology-protected by seven international invention patents across the U.S., China, Japan, Canada, and South Korea-delivers unprecedented improvements in stability, bioavailability, and targeted delivery, marking a new era in anti-aging therapeutics known as the "Microcapsule Age." To accelerate research across the globe, CELFULL has also launched its Global Research Sharing Program, offering free access to the Celfavor® NADH raw material to scientific institutions worldwide. Celfavor®NADH The only effective NADH - Celfavor ® NADH "The discovery of the therapeutic effect of stabilized NADH is more important to humankind than the discovery of antibiotics." noted Nobel Laureate Sir John Eccles, underscoring the importance of this innovation. NADH stands for "nicotinamide adenine dinucleotide (NAD) + hydrogen (H), often dubbed the "King of Anti-Aging Molecules," plays a central role in mitochondrial energy production, antioxidant defense, and the activation of longevity proteins. However, its inherent instability-sensitive to heat, light, oxygen, and stomach acid-has severely limited its clinical applications. Conventional NADH degrades by over 70% in one month at room temperature and must be stored at -20°C, making practical use difficult. 7 patents have been certified CELFULL's research team, led by its AI-powered Multi-Target Anti-Aging Institute, spent over a decade solving this problem. The result: Celfavor® NADH Microcapsules, a proprietary technology featuring 250-350μm microcapsules that protect NADH with a multi-core soluble shell made from food-grade materials. In stability tests simulating harsh conditions (40°C / 75% RH), traditional NADH retained only 3.5% of its activity after six months. By contrast, Celfavor® NADH maintained 98.3% activity-demonstrating over 6x shelf-life extension, even without refrigeration or light shielding. The stability of Celfavor® NADH microspheres The Celfavor® NADH Microcapsule system delivers innovation across four dimensions: 1. Enhanced Stability: Microcapsules shield NADH from air, moisture, light, and stomach acid, preserving its full potency in gastrointestinal conditions for up to 4 hours. 2. Targeted Release: Using AI-optimized wall material, the system enables "zero release in the stomach and sustained release in the intestine." Simulated intestinal studies show 24-hour continuous release, extending absorption time by 5-8x. 3. Superior Bioavailability: In human trials, a daily dose of 40mg led to a 98% increase in blood NAD⁺ levels, a 3.2x improvement over regular NADH. Performance also surpassed other NAD⁺ precursors like NMN and NR. 4. Formulation Flexibility: Unlike unstable NADH, Celfavor® NADH can be safely co-formulated with vitamins, coenzymes, or peptides in single or multi-ingredient capsules. Celfavor ® NADH microsphere advanced technology surpasses others Celfavor® NADH Microcapsules have been granted seven invention patents and passed all 12 safety evaluations, including cytotoxicity and long-term toxicity tests. It is currently the only NADH raw material globally to pass full-spectrum safety certification. The only globally certified raw material for toxicology and safety experiments "We are not just creating better products-we are building a platform for the future of longevity," said Dr. Juliane Hitzel, CEO of CELFULL. "With this microcapsule technology, we're launching new delivery systems for vitamins, peptides, and more. And by sharing our raw materials with global researchers, we're fostering a collaborative ecosystem that accelerates anti-aging science." From solving the NADH stability problem to advancing intelligent delivery systems, CELFULL's innovation signals a major milestone in human longevity science. As the Celfavor® NADH Microcapsule technology rolls out globally, the anti-aging industry enters a new chapter-one defined by precision, efficiency, and collaboration. For business cooperation or research partnerships, please contact:maggie@ | Email: maggie@ SOURCE: CELFULL View the original press release on ACCESS Newswire Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
5 hours ago
- Yahoo
Rocket Lab Stock Soars Higher as Neutron's Maiden Flight Nears
Rocket Lab Corp. RKLB is currently on the cusp of a transformative milestone with its highly anticipated Neutron rocket approaching its maiden flight in the second half of 2025. To expand beyond its small-launcher Electron and capture the medium-lift payload market, while positioning itself to compete with heavy-lift providers like SpaceX, Rocket Lab launched the Neutron program. This medium-class, reusable vehicle, with a potential payload capacity of approximately 15,000 kg, aims to offer flexible, cost-effective access to space for a wide range of customers, including satellite constellations, government missions, and commercial payloads. To this end, it is imperative to mention that in May 2025 Rocket Lab announced that it will launch its Neutron rocket for the U.S. Air Force Research Laboratory for a Rocket Cargo mission to support point-to-point cargo transportation, establishing a new era of commercial launch capability to advance global defense logistics for the nation. Earlier in February, the company revealed details about the ocean landing platform, a modified barge, for Neutron missions returning to Earth. Customized modification is currently ongoing on this barge, including autonomous ground support equipment to capture and secure the landed Neutron, blast shielding to protect equipment during Neutron landings, and station-keeping thrusters for precise positioning. These announcements implying consistent progress in the Neutron program have bolstered investor confidence, reflected in Rocket Lab's share price performance. While the company's year-to-date price increase has been modest, the past three months have seen a sharper uptick, underscoring growing optimism around Neutron's prospects as new milestones mentioned above are achieved. RKLB's shares gained 40% year to date, while the same soared 103.6% over the past three months. The space launch services market has been witnessing solid growth trends driven by surging demand for satellite constellations, increasing government and defense investments, and the growing need for low-cost, reliable access to space to support telecommunications, Earth observation, and national security missions. Therefore, investors interested in this business realm may keep RKLB along with other industry players like Boeing BA and Lockheed Martin LMT in their watchlist, which already enjoy an established footprint in the space launch market. Boeing's products have powered human space exploration for six decades now. The company is the prime contractor for the design, development and production of the core stage, upper stages and flight avionics suite used in NASA's Space Launch System, the only proven deep-space optimized, super-heavy lift rocket built to carry astronauts and cargo farther and faster than any rocket in history. Lockheed Martin is another space stock that has contributed significantly to various space missions with its breakthrough technologies. It is the prime contractor involved in the construction of Orion, the spacecraft that will carry the crew of four astronauts in the Artemis II lunar mission. Shares of RKLB have gained 630.8% in the past year compared with the industry's 50.9% growth. Image Source: Zacks Investment Research With respect to valuation, the company trades at a premium. RKLB currently trades at a forward 12-month Price/Sales of 22.49X compared with its industry's average of 10.06X. Image Source: Zacks Investment Research The Zacks Consensus Estimates for RKLB's 2025 and 2026 loss have improved over the past 60 days. Image Source: Zacks Investment Research RKLB stock currently carries a Zacks Rank #4 (Sell). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Boeing Company (BA) : Free Stock Analysis Report Lockheed Martin Corporation (LMT) : Free Stock Analysis Report Rocket Lab Corporation (RKLB) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio